SCHEMBL975229

SCHEMBL975229

CC(C(=O)NCCC1CCCCCCC1)N1CCN(C(=O)C2CCCCC2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 1.00
ALDH1A1 P00352 4/20 0.47
TSHR P16473 1/20 0.47
TP53 P04637 1/20 0.47
HSD11B1 P28845 1/20 0.46
BCHE P06276 1/20 0.44
LMNA P02545 1/20 0.43
CNR2 P34972 2/20 0.42
CNR1 P21554 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GAA P10253 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL973523 0.81 SIGMAR1 (1.00) SIGMAR1ALDH1A1BCHEMEN1KMT2A
SCHEMBL13503770 0.73 ALDH1A1 (0.70) SIGMAR1ALDH1A1TSHRHSD11B1LMNA
SCHEMBL9891794 0.73 SIGMAR1 (0.60) SIGMAR1BCHE
SCHEMBL24276406 0.71 SIGMAR1 (0.57) SIGMAR1BCHE
SCHEMBL20315424 0.71 ALDH1A1 (0.67) SIGMAR1ALDH1A1TSHRHSD11B1LMNA
SCHEMBL942700 0.70 SIGMAR1 (0.57) SIGMAR1BCHE
SCHEMBL10559542 0.69 ALDH1A1 (1.00) ALDH1A1TSHRTP53HSD11B1LMNA
SCHEMBL7131881 0.69 ALDH1A1 (1.00) ALDH1A1TSHRTP53HSD11B1LMNA
SCHEMBL942650 0.68 SIGMAR1 (0.52) SIGMAR1ALDH1A1TSHRTP53HSD11B1
SCHEMBL19004863 0.68 ALDH1A1 (0.61) SIGMAR1ALDH1A1TSHRHSD11B1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed